Physician profile
Nicolas Pugh
NPI 1073042461
$1,670.99
in general payments reported to CMS, 2019-2025
11 companies · $1,656 in 2025
The $1,656 reported for 2025 was more than what 75% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $14.82 · 2025: $1,656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,628 · Entertainment: $42.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,628.04 |
| Entertainment | $42.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Foundation Fusion Solutions, LLC | $376.88 | 2025 | |
| Abbott Laboratories | $270.33 | 2025 | Proclaim, Octrode |
| Medtronic, INC. | $229.40 | 2025 | Synchromedii, Intellis Adaptivestim, Accurian |
| Globus Medical, INC. | $217.63 | 2025 | Senza |
| Curonix LLC | $193.55 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spr Therapeutics, INC | $160.19 | 2025 | Sprint Pns System |
| Abbvie INC. | $85.07 | 2025 | |
| Stryker Corporation | $73.09 | 2025 | Mild Device Kit, Optablate |
| Si-Bone, INC. | $27.65 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $22.38 | 2025 | |
| Nevro Corp. | $14.82 | 2024 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicolas Pugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.